{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:07:22Z","timestamp":1789736842138,"version":"4.0.1"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2009,8,19]]},"DOI":"10.1001\/jama.2009.1201","type":"journal-article","created":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T20:18:05Z","timestamp":1250626685000},"page":"750","source":"Crossref","is-referenced-by-count":372,"title":["Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine"],"prefix":"10.1001","volume":"302","author":[{"given":"Barbara A.","family":"Slade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jama.jamanetwork.com\/ama\/content_public\/journal\/jama\/4476\/joc90070_750_757.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T01:02:05Z","timestamp":1680915725000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2009.1201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,19]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,8,19]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2009.1201","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,19]]}}}